Two tests GPs can soon offer to help spot endometriosis

Two tests GPs can soon offer – Endometriosis, a condition that affects one in 10 women globally, has long been associated with delayed diagnoses. For Ami Robertson, now 23, the struggle began at age 16 when persistent pain led to years of uncertainty. She recalls being dismissed as having irritable bowel syndrome multiple times before eventually paying for private checks that confirmed her condition. “I started to doubt myself, wondering if it was all in my head,” she said, reflecting on the emotional toll of waiting for validation. The NHS in England and Wales is set to introduce two groundbreaking, non-invasive tests to expedite diagnosis, potentially reducing the time women spend in limbo from decades to days.

Advancements in Early Detection

Under new draft guidance, GPs in England and Wales are being encouraged to use either or both of these innovative tools alongside routine assessments. The first test, known as Endotest, analyzes saliva samples for genetic markers linked to endometriosis. The second, called Endosure, measures electrical impulses in the gut using sensor pads placed on the abdomen. These methods aim to provide quicker results by identifying potential signs of the condition without requiring surgery. While they are not meant to replace traditional diagnostic procedures, experts believe they could significantly improve access to care.

The current standard for diagnosing endometriosis involves a laparoscopy—a minimally invasive procedure requiring general anesthesia. Patients often endure months or even years of symptoms before undergoing this surgery. The new tests, however, offer a simpler alternative. For Endosure, participants fast for six to eight hours and then drink water for 45 minutes to allow sensors to capture gut activity. This process is designed to detect abnormal electrical signals that may indicate the presence of endometriosis-related inflammation.

Stories of Delayed Diagnosis

Ami’s experience is echoed by many. Her journey, which included years of misdiagnosis and frustration, highlights the challenges faced by women seeking clarity. “No one should have to wait years to be believed,” she said, emphasizing the need for faster recognition of endometriosis symptoms. Similarly, Sharan Uppal, 46, from Huddersfield, described her own ordeal in diagnosing her 15-year-old daughter, Simran. “I lost count of how many times I took Simran to the GP,” Sharan shared. “We ended up in A&E three or four times, spending over 10 hours on one occasion, and nobody would take ownership.”

The breakthrough came when they opted for the gut test. The results, which were strongly positive, gave Sharan the confidence to push for a referral. “That test opened doors for us to get Simran the help she needed,” she said. Her story underscores the importance of these tools in empowering patients to advocate for their health. For Ami, the saliva test was a turning point after years of private treatment. “I paid for checks that finally confirmed my diagnosis and I went on to have surgery,” she explained, now working as a Pilates instructor in Glasgow.

How the Tests Work

The Endotest, currently in a pilot phase within the NHS, uses saliva to detect specific genetic material associated with endometriosis. This approach eliminates the need for blood draws or invasive procedures, making it more accessible. Meanwhile, Endosure, which is part of a clinical study at Worcestershire Acute NHS Hospital Trust, focuses on the gut’s electrical signals. The test requires patients to fast and drink water to stimulate gut movement, allowing sensors to gather data. Both methods are designed to complement existing diagnostic practices rather than replace them.

Healthcare professionals will oversee the implementation of these tests to ensure accuracy and proper interpretation. While not every GP will have immediate access, the NHS aims to roll them out gradually as evidence of their effectiveness is collected. The focus is on creating a system where women can receive prompt testing and early intervention, which can alleviate suffering and improve long-term outcomes.

Expert Perspectives on the Shift

Emma Cox, chief executive of Endometriosis UK, welcomed the news but stressed the importance of training for GPs and practice nurses. “Availability of these new tests needs to go hand-in-hand with education of GPs and practice nurses to ensure prompt access to those that need them,” she said. “An end to pain and symptoms not being recognized is within reach.” Her comments reflect a broader hope that these tests will not only speed up diagnosis but also reduce stigma and improve patient experiences.

The integration of these tools into routine care could mark a significant turning point. By identifying potential cases earlier, women may avoid prolonged discomfort and the risk of complications. However, challenges remain, including the need for widespread adoption and ensuring that healthcare providers are well-equipped to interpret results. The NHS is committed to gathering evidence on the tests’ performance, with plans to refine their use as more data becomes available.

The Road Ahead

For many women, the delay in diagnosis has been a source of frustration and pain. The new tests offer a glimmer of hope, but their success depends on how they are implemented. Emma Barnett, a journalist and endometriosis advocate, recently highlighted the urgency of addressing the condition: “We can’t ignore this disease that leaves one in 10 women like me in agony.” Her call to action aligns with the broader push for better awareness and resources.

Research continues to explore alternative methods, such as blood tests, which could further simplify the diagnostic process. While these innovations are promising, they require careful evaluation to ensure reliability. The goal is to create a more comprehensive approach, where multiple tools are used in conjunction to enhance accuracy. For now, the saliva and gut tests represent a critical step forward, providing women with quicker options and reducing the emotional and physical burden of prolonged uncertainty.

Ami and Sharan’s stories serve as reminders of the human cost of delayed diagnosis. Their experiences highlight the need for change, not just in medical procedures but in how healthcare systems prioritize patient voices. As these tests become more widely available, the hope is that women will no longer have to wait years to be believed. Early detection, combined with education and support, could transform the journey from symptom to diagnosis, offering a lifeline to those affected.

If you’ve waited a long time for an endometriosis diagnosis, your story matters. Share your experience to help raise awareness and drive progress in this area. The introduction of these new tools is just the beginning, and their impact will depend on how they are embraced and integrated into everyday healthcare practices.